In addition, treatment with EGFR tyrosine kinase inhibitors, erlotinib, gefitinib, or AG1478, reduced hypoxia-induced HIF-1α and CAIX expression in human GBM (Figure 6G,H). The gene discussed is HIF1A; the disease is glioblastoma.